A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum
- PMID: 23582646
- PMCID: PMC3644625
- DOI: 10.1016/j.ajhg.2013.03.018
A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum
Abstract
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) is a rare hereditary leukoencephalopathy that was originally identified by MRI pattern analysis, and it has thus far defied all attempts at identifying the causal mutation. Only 22 cases are published in the literature to date. We performed exome sequencing on five family trios, two family quartets, and three single probands, which revealed that all eleven H-ABC-diagnosed individuals carry the same de novo single-nucleotide TUBB4A mutation resulting in nonsynonymous change p.Asp249Asn. Detailed investigation of one of the family quartets with the singular finding of an H-ABC-affected sibling pair revealed maternal mosaicism for the mutation, suggesting that rare de novo mutations that are initially phenotypically neutral in a mosaic individual can be disease causing in the subsequent generation. Modeling of TUBB4A shows that the mutation creates a nonsynonymous change at a highly conserved asparagine that sits at the intradimer interface of α-tubulin and β-tubulin, and this change might affect tubulin dimerization, microtubule polymerization, or microtubule stability. Consistent with H-ABC's clinical presentation, TUBB4A is highly expressed in neurons, and a recent report has shown that an N-terminal alteration is associated with a heritable dystonia. Together, these data demonstrate that a single de novo mutation in TUBB4A results in H-ABC.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
De Novo mutations in the β-tubulin gene TUBB4: from DYT4 to leukoencephalopathy with hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC syndrome).Mov Disord. 2013 Sep;28(10):1343. doi: 10.1002/mds.25565. Epub 2013 Sep 6. Mov Disord. 2013. PMID: 24013879 No abstract available.
References
-
- van der Knaap M.S., Linnankivi T., Paetau A., Feigenbaum A., Wakusawa K., Haginoya K., Köhler W., Henneke M., Dinopoulos A., Grattan-Smith P. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology. 2007;69:166–171. - PubMed
-
- Mercimek-Mahmutoglu S., Stockler-Ipsiroglu S. Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome. Tohoku J. Exp. Med. 2007;211:95–96. author reply 97. - PubMed
-
- Mercimek-Mahmutoglu S., van der Knaap M.S., Baric I., Prayer D., Stoeckler-Ipsiroglu S. Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). Report of a new case. Neuropediatrics. 2005;36:223–226. - PubMed
-
- Wakusawa K., Uematsu M., Tsuchiya S., Haginoya K., Blau N. The cerebrospinal fluid level of 5-methylterahydrofolate in a Japanese boy with hypomyelination with atrophy of the basal ganglia and cerebellum. Tohoku J. Exp. Med. 2007;213:373. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
